Axcella Health is a biotechnology company that researches and develops novel multifactorial interventions to support health and address dysregulated metabolism. The company develops its products based on its AXA Development Platform. It offers AXA1665 for use in treating hepatic encephalopathy, AXA1125 and AXA1957 to treat non-alcoholic fatty liver disease, AXA2678 for use in treating immobilization-induced acute muscle atrophy, and AXA4010 to target multiple biological pathways.
|HQ||Cambridge, MA, US||Map|
Net income (FY, 2020)
EBIT (FY, 2020)
Market capitalization (6-May-2022)
Closing stock price (6-May-2022)
|Company Name||Date||Deal Size|
|Acora Nutrition LLC|
|Axcella Health Securities Corporation|
When was Axcella Health founded?
Axcella Health was founded in 2010.
Who are Axcella Health key executives?
Axcella Health's key executives are David R. Epstein, Bill Hinshaw and Alison Schecter.
How many employees does Axcella Health have?
Axcella Health has 49 employees.
Who are Axcella Health competitors?
Competitors of Axcella Health include Elektrofi, Jubilant Pharma and MyMeds&Me.
Where is Axcella Health headquarters?
Axcella Health headquarters is located at 5 Memorial Dr, Cambridge.
Where are Axcella Health offices?
Axcella Health has an office in Cambridge.
How many offices does Axcella Health have?
Axcella Health has 1 office.
Receive alerts for 300+ data fields across thousands of companies